Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Live Attenuated Influenza Vaccine”

108 trials

Showing 20 of 108 results

Post-approval studies (Phase 4)Study completedNCT03502291
What this trial is testing

The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study

Who this might be right for
PneumoniaInfluenza, Human
Liverpool University Hospitals NHS Foundation Trust 324
Post-approval studies (Phase 4)WithdrawnNCT03884296
What this trial is testing

Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood

Who this might be right for
Influenza
Stanford University
Early research (Phase 1)Study completedNCT01488188
What this trial is testing

Immunogenicity and Safety of Live Attenuated Influenza Vaccine (Flumist) Administered by Nasal and Sublingual Route

Who this might be right for
Healthy
International Vaccine Institute 40
Early research (Phase 1)Study completedNCT03300050
What this trial is testing

Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine

Who this might be right for
InfluenzaVaccine
PATH 65
Early research (Phase 1)Study completedNCT00722774
What this trial is testing

Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Post-approval studies (Phase 4)Study completedNCT02967393
What this trial is testing

Influenza Vaccine Feasibility Study in Children With Persistent Asthma

Who this might be right for
Asthmatic
Vanderbilt University Medical Center 40
Post-approval studies (Phase 4)Study completedNCT06987942
What this trial is testing

Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)

Who this might be right for
VaricellaInfluenza Vaccine
Sinovac (Dalian) Vaccine Technology Co., Ltd. 899
Early research (Phase 1)UnknownNCT05056519
What this trial is testing

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Who this might be right for
Influenza Prevention
Changchun BCHT Biotechnology Co. 160
Post-approval studies (Phase 4)Study completedNCT00138385
What this trial is testing

Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT00922259
What this trial is testing

Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7

Who this might be right for
Influenza A
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)Study completedNCT00347672
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Study completedNCT00734175
What this trial is testing

Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT00724997
What this trial is testing

Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers

Who this might be right for
Seasonal Human Influenza
AVIR Green Hills Biotechnology AG 48
Early research (Phase 1)Study completedNCT03926416
What this trial is testing

Safety Study of Live Attenuated Influenza Vaccine, CodaVax

Who this might be right for
Influenza
Codagenix, Inc 125
Post-approval studies (Phase 4)Study completedNCT03101462
What this trial is testing

Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years

Who this might be right for
Influenza
St. Louis University 38
Post-approval studies (Phase 4)Ended earlyNCT03020472
What this trial is testing

Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age

Who this might be right for
Influenza
Stanford University 6
Testing effectiveness (Phase 2)UnknownNCT05284851
What this trial is testing

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Who this might be right for
Influenza Prevention
Changchun BCHT Biotechnology Co. 2,520
Post-approval studies (Phase 4)Study completedNCT03023683
What this trial is testing

Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)

Who this might be right for
Influenza
Stanford University 18
Very early researchActive Not RecruitingNCT05921448
What this trial is testing

Vaccine Pandemic Preparedness Through Airway Immunology Characterization

Who this might be right for
Influenza, Human
Copenhagen Respiratory Research 60
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation